Related Experiment Video

Updated: Jun 13, 2026

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
11:28

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques

Published on: March 13, 2015

Difficulties in interpreting HbA(1c) results

Katarzyna Homa1, Liliana Majkowska

  • 1Department of Diabetology and Internal Diseases, Pomeranian Medical University, Szczecin, Poland. kasho@interia.pl

Polskie Archiwum Medycyny Wewnetrznej
|April 29, 2010
PubMed

Insights

Glycated hemoglobin (HbA1c) tests are crucial for diabetes management and diagnosis. However, results may require cautious interpretation and alternative markers like fructosamine when they don't align with patient glycemia and symptoms.

Area of Science:

  • Clinical Chemistry
  • Endocrinology
  • Diabetes Mellitus Research

Background:

  • Glycated hemoglobin (HbA1c) is a key biomarker for assessing glycemic control in diabetes.
  • The American Diabetes Association (ADA) guidelines recommend frequent HbA1c testing for diabetes management and diagnosis.
  • High-pressure liquid chromatography (HPLC) is recognized as the reference method for HbA1c measurement.

Purpose of the Study:

  • To review the role and limitations of HbA1c testing in diabetes care.
  • To highlight circumstances where HbA1c results may lack clinical reliability.
  • To suggest alternative glycemic control markers when HbA1c is inconclusive.

Main Methods:

  • Review of American Diabetes Association (ADA) standards for HbA1c testing.
  • Discussion of high-pressure liquid chromatography (HPLC) as a reference method.
  • Identification of clinical scenarios and conditions affecting HbA1c test accuracy.

Main Results:

  • HbA1c testing frequency recommendations vary based on clinical stability and treatment goals.
  • HPLC is the established reference method for HbA1c quantification.
  • Certain conditions can compromise the clinical reliability of HbA1c results.

Conclusions:

  • HbA1c is vital for diabetes assessment, but results must be interpreted cautiously.
  • When HbA1c levels conflict with clinical data, alternative diagnostic methods are advised.
  • Fructosamine and 1,5-anhydroglucitol are potential alternative markers for glycemic control assessment.

Related Concept Videos

Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
SBAR II: Application of SBAR01:14

SBAR II: Application of SBAR

SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...